Clinical trial
Randomized, Controlled, Double-blind, Parallel, Multicentric Study to Investigate Support of the Colonization Resistance of the Gut Microbiota with the Synbiotic Food Supplement Nagasin® After Disturbance by Antimicrobial Treatment
NCT05800704 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Controlled, Double-blind, Parallel, Multicentric Study to Investigate Support of the Colonization Resistance of the Gut Microbiota with the Synbiotic Food Supplement Nagasin® After Disturbance by Antimicrobial Treatment
- Lead sponsor
- University of Zurich
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 10, 2023
- Completion date
- March 31, 2025
- Enrollment
- 49 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
c. difficile enteritis